Laura Ramos
Hospital Universitario de Canarias
39 Papers
22 Citations
Laura Ramos is an academic researcher from Hospital Universitario de Canarias. The author has contributed to research in topics: Medicine & Inflammatory bowel disease. The author has an hindex of 10, co-authored 23 publications.
Chat about Author
Papers
Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.
María José Casanova,María Chaparro,Valle García-Sánchez,Óscar Nantes,E Leo,M Rojas-Feria,Aranzazu Jauregui-Amezaga,Santiago García-López,José María Huguet,Federico Argüelles-Arias,M Aicart,Ignacio Marín-Jiménez,María Gómez-García,Fernando Muñoz,M Esteve,Luis Bujanda,Xavier Cortés,Joan Tosca,J R Pineda,Míriam Mañosa,Jordina Llaó,Jordi Guardiola,Isabel Pérez-Martínez,C Muñoz,Yago González-Lama,Joaquín Hinojosa,J M Vázquez,M. P. Martínez-Montiel,Gloria Esther Rodriguez,R. Pajares,M F García-Sepulcre,Álvaro Hernández-Martínez,J.L. Pérez-Calle,Belén Beltrán,David Busquets,Laura Ramos,Fernando Bermejo,Jesús Barrio,M. Barreiro-de Acosta,O Roncedo,Xavier Calvet,Daniel Hervías,Fernando Gomollón,Mercedes Domínguez-Antonaya,Guillermo Alcain,Beatriz Sicilia,Carmen Duenas,Alexandra Gutierrez,R Lorente-Poyatos,Manuel Domínguez,Sam Khorrami,Carlos Taxonera,A Rodríguez-Pérez,Ángel Ponferrada,M. Van Domselaar,M L Arias-Rivera,Olga Merino,E Castro,J M Marrero,María Dolores Martín-Arranz,B. Botella,Luis Fernández-Salazar,David Monfort,V. Opio,Antonio García-Herola,M Menacho,P Ramírez-de la Piscina,D Ceballos,Pedro Almela,M Navarro-Llavat,V Robles-Alonso,A B Vega-López,Irene Moraleja,M T Novella,Carlos Castaño-Milla,A Sánchez-Torres,José Manuel Benítez,Cristina Rodríguez,Luísa Castro,Elena Garrido,E. Domènech,Esther Garcia-Planella,Javier P. Gisbert +82 more
TL;DR: The incidence rate of inflammatory bowel disease relapse after anti-TNF discontinuation is relevant and some predictive factors of relapse afterAnti-tumor necrosis factor drugs withdrawal have been identified and treatment with the same anti- TNF drug was effective and safe.
108
Tofacitinib in Ulcerative Colitis: Real-world Evidence From the ENEIDA Registry
María Chaparro,Ana Garre,Francisco Mesonero,Cristina Rodríguez,Manuel Barreiro-de Acosta,J Martínez-Cadilla,María T Arroyo,Noemí Manceñido,Monica Sierra-Ausin,Isabel Vera-Mendoza,María José Casanova,Pilar Nos,C González-Muñoza,Teresa Torrano Martínez,Maia Boscá-Watts,M Calafat,David Busquets,Eva Girona,Jordina Llaó,María Dolores Martín-Arranz,M Piqueras,Laura Ramos,G Suris,Fernando Bermejo,Ana Yaiza Carbajo,Diego Casas-Deza,Agnès Fernández-Clotet,María Josefa Bernalte García,Daniel Ginard,Ana Gutiérrez-Casbas,Luis Hernández,Alfredo J. Lucendo,Lucía Márquez,Olga Merino-Ochoa,Francisco J Rancel,Carlos Taxonera,Antonio López Sanromán,Saioa Rubio,Eugeni Domènech,Javier P. Gisbert +39 more
TL;DR: Tofacitinib is effective and safe in UC patients in real practice, even in a highly refractory cohort, and a relevant proportion of patients discontinue the drug over time, mainly due to primary failure.
81
Risk factors for inadequate bowel preparation: a validated predictive score
Antonio Z. Gimeno-García,Jose Luis Baute,Goretti Hernández,Dalia Morales,Carmen Delia Gonzalez-Pérez,David Nicolás-Pérez,Onofre Alarcón-Fernández,Alejandro Jiménez,Manuel Hernández-Guerra,Rafael Romero,Inmaculada Alonso,Yanira González,Zaida Adrian,Marta Carrillo,Laura Ramos,Enrique Quintero +15 more
TL;DR: A simple score may assist the clinician in predicting which patients are at high risk of inadequate bowel cleanliness, and may guide changes in bowel preparation strategy accordingly.
75
Effectiveness and safety of ustekinumab in ulcerative colitis: Real-world evidence from the ENEIDA registry.
María Chaparro,Ana Garre,Marisa Iborra,M Sierra,Manuel Barreiro-de Acosta,Agnès Fernández-Clotet,Luisa de Castro,Maia Boscá-Watts,María José Casanova,A. Lopez-Garcia,Rufo Lorente,Cristina Rodríguez,Ana Yaiza Carbajo,María Teresa Arroyo,Ana Gutiérrez,Joaquín Hinojosa,Teresa Martínez-Pérez,Albert Villoria,Fernando Bermejo,David Busquets,Blau Camps,Fiorella Cañete,Noemí Manceñido,David Monfort,M Navarro-Llavat,José Lázaro Pérez-Calle,Laura Ramos,Montserrat Rivero,Teresa Angueira,Patricia Camo,Daniel Carpio,Irene García-de-la-Filia,C González-Muñoza,Luis Hernández,José María Huguet,Victor J. Morales,Beatriz Sicilia,Pablo Vega,Isabel Vera,Yamile Zabana,Pilar Nos,Patricia Suárez Álvarez,Cristina Calviño-Suarez,Elena Ricart,Vicent Hernández,Miguel Minguez,Lucía Márquez,Daniel Hervías Cruz,Saioa Rubio Iturria,Jesus Barrio +49 more
TL;DR: Evaluated the effectiveness and safety of ustekinumab in UC in real life, finding benefit in some UC patients in real practice, even in a very refractory cohort in which the drug was prescribed as last resort.
68
Comparison of Two Intensive Bowel Cleansing Regimens in Patients With Previous Poor Bowel Preparation: A Randomized Controlled Study
Antonio Z. Gimeno-García,Goretti Hernández,Ana Aldea,David Nicolás-Pérez,Alejandro Jiménez,Marta Carrillo,Vanesa Felipe,Onofre Alarcón-Fernández,Manuel Hernández-Guerra,Rafael Romero,Inmaculada Alonso,Yanira González,Zaida Adrian,Miguel Moreno,Laura Ramos,Enrique Quintero +15 more
TL;DR: After 3-day low-residue diet and oral bisacodyl before colonoscopy, colon cleansing was superior to 2-L split-dose PEG+Asc in patients with previous inadequate cleansing, confirming the superiority of 4-L PEG preparation.
63